Phase 1 Eczema Trial, Recruiting NCT07558668 Sponsor: Sitryx Therapeutics Ltd Condition: Eczema
Back to Eczema

Phase 1 Eczema Trial, Recruiting

NCT07558668
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For Parts 1 & 2 (Healthy Volunteers):

  • You are a man or woman aged 18 to 65 years old, in general good health, with a body weight in the normal to slightly overweight range (BMI between 18 and 32)
  • Women must either not be able to get pregnant, or must not be sexually active
  • Your blood tests, heart trace (ECG), and other health measurements must show no significant problems

For Part 3 (Atopic Dermatitis Patients):

  • You are a man or woman aged 18 to 65 years old with a confirmed diagnosis of active atopic dermatitis (eczema), with a BMI of 40 or below
  • Your eczema covers at least 10% of your body surface area at the time of screening and at the start of the study
  • Your eczema severity, as measured by a standard medical scoring tool (EASI), must be rated at 16 or above at screening and at the start of the study
  • A doctor must assess your eczema as at least "moderate" using a standard rating scale at screening and at the start of the study
  • Your itch level, rated on a scale of 0–10, must be at least 4 at screening and at the start of the study

Who may not be able to join:

For Parts 1 & 2:

  • You have taken any prescription or non-prescription medicines, vitamins, herbal products, or dietary supplements within approximately the last 35 days (or longer, depending on the medicine)

For Part 3:

  • You have any significant health condition or abnormal test results that the study doctor believes could put you at risk (confirm with trial site)
  • You have certain medical history conditions listed in the full study rules (confirm with trial site)
  • You have recently received certain treatments listed in the full study rules (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Sitryx Therapeutics, Study Sponsor

Phone: +44 (0)1865 648401

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Sitryx Therapeutics Ltd
Registry
ClinicalTrials.gov
Start date
26 February 2025
Est. completion
30 August 2026

Where this trial is recruiting

🇧🇬 Bulgaria 🇩🇰 Denmark 🇩🇪 Germany 🇮🇪 Ireland 🇬🇧 United Kingdom 🇺🇸 United States

Primary endpoints

The Proportion of Participants With Treatment-Emergent Adverse Events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov